Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A09220 | 31832567 | Hepatol Commun | Designing Clinical Trials in Pediatric Nonalcoholic Steatohepatitis: Tips for Patient Selection and Appropriate Endpoints. | 2019 | Details |
| A09221 | 31832499 | GE Port J Gastroenterol | Fatty Liver Caused by Glycogen Storage Disease Type IX: A Small Series of Cases in Children. | 2019 | Details |
| A09222 | 31832001 | World J Gastroenterol | LB100 ameliorates nonalcoholic fatty liver disease via the AMPK/Sirt1 pathway. | 2019 | Details |
| A09223 | 31831718 | Aging (Albany NY) | Bone morphogenetic protein 4 (BMP4) alleviates hepatic steatosis by increasing hepatic lipid turnover and inhibiting the mTORC1 signaling axis in hepatocytes. | 2019 | Details |
| A09224 | 31831621 | J Biol Chem | Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis. | 2019 | Details |
| A09225 | 31831037 | J Exp Clin Cancer Res | Ischemia reperfusion injury promotes recurrence of hepatocellular carcinoma in fatty liver via ALOX12-12HETE-GPR31 signaling axis. | 2019 | Details |
| A09226 | 31829750 | Expert Opin Investig Drugs | Trends in pioglitazone use among U.S. adults with type 2 diabetes and suspected nonalcoholic fatty liver disease. | 2019 | Details |
| A09227 | 31828683 | Eur J Clin Microbiol Infect Dis | Non-alcoholic fatty liver diseases: from role of gut microbiota to microbial-based therapies. | 2019 | Details |
| A09228 | 31828503 | Langenbecks Arch Surg | A retrospective case control study identifies peripheral blood mononuclear cell albumin RNA expression as a biomarker for non-alcoholic fatty liver disease. | 2019 | Details |
| A09229 | 31827504 | Gastroenterol Res Pract | Increased Serum Angiotensin II Is a Risk Factor of Nonalcoholic Fatty Liver Disease: A Prospective Pilot Study. | 2019 | Details |
| A09230 | 31827150 | Sci Rep | Association of circulating miR-20a, miR-27a, and miR-126 with non-alcoholic fatty liver disease in general population. | 2019 | Details |
| A09231 | 31826372 | Asia Pac J Clin Nutr | Association between serum ferritin and non-alcoholic fatty liver disease among middle-aged and elderly Chinese with normal weight. | 2019 | Details |
| A09232 | 31826069 | J Gastrointestin Liver Dis | PNPLA3 I148M Polymorphism in Patients with Nonalcoholic Fatty Liver Disease, Obesity and Prediabetes. | 2019 | Details |
| A09233 | 31826068 | J Gastrointestin Liver Dis | Characterization of Patients with Biopsy-Proven Non-Alcoholic Fatty Liver Disease and Normal Aminotransferase Levels. | 2019 | Details |
| A09234 | 31826063 | J Gastrointestin Liver Dis | Cardiac Arrhythmias and Electrocardiogram Modifications in Non-Alcoholic Fatty Liver Disease. A Systematic Review. | 2019 | Details |
| A09235 | 31825539 | Aliment Pharmacol Ther | Plasma metabolic alterations in patients with severe obesity and non-alcoholic steatohepatitis. | 2019 | Details |
| A09236 | 31824620 | Middle East J Dig Dis | Burden of Liver Diseases: A Review from Iran. | 2019 | Details |
| A09237 | 31823449 | Liver Int | Controlled attenuation parameter reflects steatosis in compensated advanced chronic liver disease. | 2019 | Details |
| A09238 | 31822978 | Eur Radiol | Quantification of hepatic steatosis with ultrasound: promising role of attenuation imaging coefficient in a biopsy-proven cohort. | 2019 | Details |
| A09239 | 31822739 | Sci Rep | Pharmacological myeloperoxidase (MPO) inhibition in an obese/hypertensive mouse model attenuates obesity and liver damage, but not cardiac remodeling. | 2019 | Details |
| A09241 | 31821689 | Liver Int | Longitudinal studies can identify distinct inflammatory cytokines associated with the inhibition or progression of liver cancer. | 2019 | Details |
| A09242 | 31821039 | Am J Physiol Endocrinol Metab | Amitriptyline inhibits nonalcoholic steatohepatitis and atherosclerosis induced by high-fat diet and LPS through modulation of sphingolipid metabolism. | 2019 | Details |
| A09243 | 31820847 | Liver Int | Associations of subclinical atherosclerosis with nonalcoholic fatty liver disease and fibrosis assessed by non-invasive score. | 2019 | Details |
| A09245 | 31819934 | Food Funct | Acerola polysaccharides ameliorate high-fat diet-induced non-alcoholic fatty liver disease through reduction of lipogenesis and improvement of mitochondrial functions in mice. | 2020 | Details |
| A09246 | 31819566 | Diabetes Metab Syndr Obes | Hepatic Steatosis Index Is Associated with Type 1 Diabetes Complications. | 2019 | Details |
| A09247 | 31819375 | Drug Des Devel Ther | Liraglutide Improves Non-Alcoholic Fatty Liver Disease In Diabetic Mice By Modulating Inflammatory Signaling Pathways. | 2019 | Details |
| A09248 | 31818232 | Int J Vitam Nutr Res | Efficacy of phytosomal curcumin among patients with non-alcoholic fatty liver disease. | 2019 | Details |
| A09249 | 31817648 | Nutrients | High Protein Diet and Metabolic Plasticity in Non-Alcoholic Fatty Liver Disease: Myths and Truths. | 2019 | Details |
| A09250 | 31817623 | J Clin Med | Higher Sodium Intake Assessed by 24 Hour Urinary Sodium Excretion Is Associated with Non-Alcoholic Fatty Liver Disease: The PREVEND Cohort Study. | 2019 | Details |
| A09251 | 31817398 | Nutrients | Mediterranean Diet and NAFLD: What We Know and Questions That Still Need to Be Answered. | 2019 | Details |
| A09252 | 31817258 | Cells | Ubiquitin-Like Post-Translational Modifications (Ubl-PTMs): Small Peptides with Huge Impact in Liver Fibrosis. | 2019 | Details |
| A09253 | 31817227 | Nutrients | Fermented Korean Red Ginseng Extract Enriched in Rd and Rg3 Protects against Non-Alcoholic Fatty Liver Disease through Regulation of mTORC1. | 2019 | Details |
| A09254 | 31816816 | Int J Mol Sci | MicroRNA-451 and Genistein Ameliorate Nonalcoholic Steatohepatitis in Mice. | 2019 | Details |
| A09255 | 31816412 | Biochim Biophys Acta Mol Cell Biol Lipids | Aquaporin-9 is involved in the lipid-lowering activity of the nutraceutical silybin on hepatocytes through modulation of autophagy and lipid droplets composition. | 2019 | Details |
| A09256 | 31816064 | Hum Mol Genet | Fenofibrate rapidly decreases hepatic lipid and glycogen storage in neonatal mice with glycogen storage disease type Ia. | 2020 | Details |
| A09257 | 31815784 | Curr Opin Endocrinol Diabetes Obes | Gastrointestinal peptides and nonalcoholic fatty liver disease. | 2020 | Details |
| A09258 | 31815116 | Front Cell Dev Biol | Corrigendum: NFκB/Orai1 Facilitates Endoplasmic Reticulum Stress by Oxidative Stress in the Pathogenesis of Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A09259 | 31814783 | Hepat Med | A Review Of Current And Upcoming Treatment Modalities In Non-Alcoholic Fatty Liver Disease And Non-Alcoholic Steatohepatitis. | 2019 | Details |
| A09261 | 31813633 | Lancet | Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. | 2019 | Details |
| A09263 | 31813265 | Antioxid Redox Signal | Redox Regulation via Glutaredoxin-1 and Protein S-Glutathionylation. | 2020 | Details |
| A09264 | 31812658 | Clin Gastroenterol Hepatol | Low Testosterone Is Associated With Nonalcoholic Steatohepatitis and Fibrosis Severity in Men. | 2019 | Details |
| A09265 | 31812510 | Gastroenterology | Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension. | 2019 | Details |
| A09267 | 31811953 | Clin Gastroenterol Hepatol | Keratin 18 Is a Diagnostic and Prognostic Factor for Acute Alcoholic Hepatitis. | 2019 | Details |
| A09268 | 31810868 | Clin Res Hepatol Gastroenterol | Active vitamin D impedes the progression of non-alcoholic fatty liver disease by inhibiting cell senescence in a rat model. | 2019 | Details |
| A09269 | 31810499 | Syst Rev | The impact of environmental cadmium exposure on type 2 diabetes risk: a protocol for an overview of systematic reviews. | 2019 | Details |
| A09270 | 31810110 | Pediatr Obes | Prevalence of prediabetes and type 2 diabetes in children with obesity and increased transaminases in European German-speaking countries. Analysis of the APV initiative. | 2019 | Details |
| A09271 | 31809956 | Nutrition | Intermediary effect of inflammation on the association between dietary patterns and non-alcoholic fatty liver disease. | 2019 | Details |
| A09272 | 31809318 | Chin Med J (Engl) | Association of leukocyte telomere length with non-alcoholic fatty liver disease in patients with type 2 diabetes. | 2019 | Details |
| A09273 | 31809303 | J Chin Med Assoc | CircularRNA as novel biomarkers in liver diseases. | 2020 | Details |
| A09275 | 31809000 | J Cell Mol Med | Long non-coding RNA (lncRNA) H19 induces hepatic steatosis through activating MLXIPL and mTORC1 networks in hepatocytes. | 2019 | Details |
| A09276 | 31808577 | Hepatology | Increased Liver Localization of Lipopolysaccharides in Human and Experimental NAFLD. | 2020 | Details |
| A09277 | 31808444 | Cureus | Lifestyle Intervention Framework for Obese Patients with Non-alcoholic Fatty Liver Disease - a Tool for Health Professionals in Resource Constraint Settings. | 2019 | Details |
| A09278 | 31808322 | J Korean Med Sci | Correlation of Clinical and Histopathologic Parameters with Ultrasonographic Grades in Pediatric Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
| A09279 | 31808236 | Hepatol Res | Serum soluble sialic acid-binding immunoglobulin-like lectin-7 concentration as an indicator of liver macrophage activation and advanced fibrosis in patients with non-alcoholic fatty liver disease. | 2019 | Details |
| A09280 | 31808097 | Environ Sci Pollut Res Int | Could phthalates exposure contribute to the development of metabolic syndrome and liver disease in humans? | 2019 | Details |
| A09281 | 31807383 | Cureus | Effect of Non-alcoholic Fatty Liver Disease on Transaminase Levels and Transient Elastography in Patients with Chronic Hepatitis B. | 2019 | Details |
| A09282 | 31806905 | Nat Med | Chronic inflammation in the etiology of disease across the life span. | 2019 | Details |
| A09283 | 31806408 | Arab J Gastroenterol | Treatments of nonalcoholic fatty liver disease in adults who have no other illness: A Review article. | 2019 | Details |
| A09284 | 31805951 | Lipids Health Dis | Target genes associated with lipid and glucose metabolism in non-alcoholic fatty liver disease. | 2019 | Details |
| A09285 | 31805752 | Molecules | Effects of Propolis Extract and Propolis-Derived Compounds on Obesity and Diabetes: Knowledge from Cellular and Animal Models. | 2019 | Details |
| A09286 | 31805573 | Horm Res Paediatr | Increased Prevalence of Severe Obesity and Related Comorbidities among Patients Referred to a Pediatric Obesity Clinic during the Last Decade. | 2019 | Details |
| A09287 | 31805072 | PLoS One | Hyperglycemia induces key genetic and phenotypic changes in human liver epithelial HepG2 cells which parallel the Leprdb/J mouse model of non-alcoholic fatty liver disease (NAFLD). | 2019 | Details |
| A09288 | 31805015 | J Clin Invest | Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease. | 2020 | Details |
| A09289 | 31804575 | Sci Rep | Deep learning enables pathologist-like scoring of NASH models. | 2019 | Details |
| A09290 | 31804025 | Environ Toxicol | Burdock (Arctium lappa L.) root attenuates preneoplastic lesion development in a diet and thioacetamide-induced model of steatohepatitis-associated hepatocarcinogenesis. | 2019 | Details |
| A09291 | 31803887 | Food Funct | The regulatory effects of phytosterol esters (PSEs) on gut flora and faecal metabolites in rats with NAFLD. | 2020 | Details |
| A09292 | 31803542 | PeerJ | Polyphenol-rich Trapa quadrispinosa pericarp extract ameliorates high-fat diet induced non-alcoholic fatty liver disease by regulating lipid metabolism and insulin resistance in mice. | 2019 | Details |
| A09293 | 31803485 | BMJ Open Diabetes Res Care | Determinants of longitudinal change in insulin clearance: the Prospective Metabolism and Islet Cell Evaluation cohort. | 2019 | Details |
| A09294 | 31803464 | Ther Adv Endocrinol Metab | Reduced physical activity in young and older adults: metabolic and musculoskeletal implications. | 2019 | Details |
| A09295 | 31802390 | Hepatol Int | New drugs for NAFLD: lessons from basic models to the clinic. | 2019 | Details |
| A09296 | 31801616 | J Transl Med | Microbiota, type 2 diabetes and non-alcoholic fatty liver disease: protocol of an observational study. | 2019 | Details |
| A09299 | 31800606 | PLoS One | ABO blood group and risk of newly diagnosed nonalcoholic fatty liver disease: A case-control study in Han Chinese population. | 2019 | Details |
| A09300 | 31800592 | PLoS One | Myeloid cell deletion of Aryl hydrocarbon Receptor Nuclear Translocator (ARNT) induces non-alcoholic steatohepatitis. | 2019 | Details |
| A09301 | 31799714 | Phytother Res | The effects of curcumin supplementation on body mass index, body weight, and waist circumference in patients with nonalcoholic fatty liver disease: A systematic review and dose-response meta-analysis of randomized controlled trials. | 2019 | Details |
| A09302 | 31799678 | Eur Rev Med Pharmacol Sci | MicroRNA-205 ameliorates lipid accumulation in non-alcoholic fatty liver disease through targeting NEU1. | 2019 | Details |
| A09303 | 31799206 | Liver Cancer | NAFLD-Associated Comorbidities in Advanced Stage HCC Do Not Alter the Safety and Efficacy of Yttrium-90 Radioembolization. | 2019 | Details |
| A09304 | 31798277 | World J Gastroenterol | Mitochondrial metabolomic profiling for elucidating the alleviating potential of Polygonatum kingianum against high-fat diet-induced nonalcoholic fatty liver disease. | 2019 | Details |
| A09305 | 31797589 | Pac Symp Biocomput | Automated phenotyping of patients with non-alcoholic fatty liver disease reveals clinically relevant disease subtypes. | 2020 | Details |
| A09306 | 31797544 | Mol Nutr Food Res | Vitamin D Deficiency Induces Insulin Resistance and Re-Supplementation Attenuates Hepatic Glucose Output via the PI3K-AKT-FOXO1 Mediated Pathway. | 2020 | Details |
| A09307 | 31797186 | Dig Dis Sci | Impact of NAFLD on the Incidence of Cardiovascular Diseases in a Primary Care Population in Germany. | 2019 | Details |
| A09308 | 31796953 | Am J Clin Nutr | Metabolic effects of a prolonged, very-high-dose dietary fructose challenge in healthy subjects. | 2020 | Details |
| A09309 | 31796646 | Aging (Albany NY) | HIF-2α upregulation mediated by hypoxia promotes NAFLD-HCC progression by activating lipid synthesis via the PI3K-AKT-mTOR pathway. | 2019 | Details |
| A09310 | 31795988 | BMC Public Health | First-degree family history of diabetes and its relationship with serum osteocalcin levels independent of liver fat content in a non-diabetic Chinese cohort. | 2019 | Details |
| A09311 | 31795627 | Clin Mol Hepatol | Limited expression of TLR9 on T cells and its functional consequences in patients with nonalcoholic fatty liver disease. | 2019 | Details |
| A09312 | 31795496 | Cells | Pin1 Plays Essential Roles in NASH Development by Modulating Multiple Target Proteins. | 2019 | Details |
| A09313 | 31795130 | Nutrients | Lotus Seedpod Extracts Reduced Lipid Accumulation and Lipotoxicity in Hepatocytes. | 2019 | Details |
| A09314 | 31793675 | J Food Biochem | Ganoderma polysaccharide and chitosan synergistically ameliorate lipid metabolic disorders and modulate gut microbiota composition in high fat diet-fed golden hamsters. | 2019 | Details |
| A09315 | 31793624 | J Clin Endocrinol Metab | Serum SHBG Is Associated With the Development and Regression of Nonalcoholic Fatty Liver Disease: A Prospective Study. | 2020 | Details |
| A09316 | 31793324 | Nutr Hosp | Immunonutritional contribution of gut microbiota to fatty liver disease. | 2020 | Details |
| A09317 | 31793207 | J Cell Mol Med | PNPLA3 I148M mediates the regulatory effect of NF-kB on inflammation in PA-treated HepG2 cells. | 2019 | Details |
| A09318 | 31792455 | Nat Med | Three-dimensional spatially resolved geometrical and functional models of human liver tissue reveal new aspects of NAFLD progression. | 2019 | Details |
| A09322 | 31790897 | Phytomedicine | Triterpenic acids-enriched fraction from Cyclocarya paliurus attenuates insulin resistance and hepatic steatosis via PI3K/Akt/GSK3β pathway. | 2019 | Details |
| A09323 | 31790895 | Phytomedicine | Amelioration of non-alcoholic steatohepatitis by Qushi Huayu decoction is associated with inhibition of the intestinal mitogen-activated protein kinase pathway. | 2019 | Details |
| A09324 | 31790829 | Free Radic Biol Med | Lycopene prevents the progression of lipotoxicity-induced nonalcoholic steatohepatitis by decreasing oxidative stress in mice. | 2019 | Details |
| A09325 | 31790429 | PLoS One | Three-dimensional analysis of pancreatic fat by fat-water magnetic resonance imaging provides detailed characterization of pancreatic steatosis with improved reproducibility. | 2019 | Details |
| A09326 | 31789950 | Eur J Gastroenterol Hepatol | Performance of liver biomarkers, in patients at risk of nonalcoholic steato-hepatitis, according to presence of type-2 diabetes. | 2020 | Details |
| A09327 | 31789772 | J Pediatr Gastroenterol Nutr | The rs72613567: TA Variant in the Hydroxysteroid 17-beta Dehydrogenase 13 Gene Reduces Liver Damage in Obese Children. | 2020 | Details |
| A09328 | 31789757 | J Clin Gastroenterol | The Role of Noninvasive Tests for Differentiating NASH From NAFL and Diagnosing Advanced Fibrosis Among Patients With NAFLD. | 2020 | Details |
| A09329 | 31789677 | Curr Opin Lipidol | Fatty liver, cardiometabolic disease and mortality. | 2020 | Details |
| A09330 | 31789009 | Minerva Cardioangiol | The association between non-alcoholic fatty liver disease and valvular heart disease. | 2019 | Details |